Equity Risk AnalysisZevra Therapeutics trades at 80% discount to peers on single-drug dependency riskViaNews Editorial Team (Markets)•Feb 25, 2026
Equity Risk AnalysisCopa Holdings' Tocumen Dependency: Why Single-Hub Concentration Risk Could Rattle InvestorsViaNews Editorial Team (Markets)•Feb 18, 2026
Earnings RiskDentsu's Single-Entity Profit Trap: Why Investors Should Watch Dentsu Inc. CloselyViaNews Editorial Team (Markets)•Feb 18, 2026